Flushing Oral Oncology Drugs Down the Toilet
- 20 October 2011
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (30), 3958-3959
- https://doi.org/10.1200/jco.2011.37.1617
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Influence of Therapeutic Complexity on Medication Adherence in the NetherlandsArchives of Internal Medicine, 2011
- Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009Clinical Pharmacology & Therapeutics, 2010
- Inconsistent Labeling of Food Effect for Oral Agents across Therapeutic Areas: Differences between Oncology and Non-Oncology ProductsClinical Cancer Research, 2010
- Food and Oral Antineoplastics: More Than Meets the EyeClinical Cancer Research, 2010
- Phase I Clinical Trial of the CYP17 Inhibitor Abiraterone Acetate Demonstrating Clinical Activity in Patients With Castration-Resistant Prostate Cancer Who Received Prior Ketoconazole TherapyJournal of Clinical Oncology, 2010
- The Value Meal: How to Save $1,700 Per Month or More on LapatinibJournal of Clinical Oncology, 2007
- A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of FundamentalsThe Journal of Clinical Pharmacology, 2002